Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Apremilast may be a promising long-term treatment for hidradenitis suppurativa.

Amputation stump skin disease worsens life quality, especially in men during summer, and long prosthesis use increases fungal infection risk.

New grading scale accurately measures hair loss severity and treatment effectiveness.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Both treatments help with hair regrowth in alopecia areata, but azathioprine has milder side effects than betamethasone.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

Alopecia areata and atopic dermatitis have similar healthcare costs, but alopecia areata leads to more outpatient and long-term disability expenses.

Lupus nephritis patients face more challenges in family planning, work, symptoms, medication, and quality of life than those without it.

Baricitinib effectively regrows hair in severe alopecia areata cases.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

Baricitinib is an effective treatment for severe alopecia areata.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Baricitinib may help people with long-term alopecia areata.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Alopecia areata significantly affects emotional well-being and quality of life, especially in younger adults.

Trichoscopy can help diagnose and assess disease activity in connective tissue diseases by identifying specific hair and scalp signs.

Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disorders.

Serum IMA levels don't help diagnose AGA but may indicate its severity.